SCHEMBL5281205

SCHEMBL5281205

NCCNC(=O)c1ccc(C(=O)CNCCOC(=O)N(c2ccccc2-c2ccccc2)N2CC[CH]CC2)s1

nearest known ligand 0.32

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
ACKR3 P25106 9/20 0.32
RXFP1 Q9HBX9 1/20 0.32
CHEK1 O14757 1/20 0.32
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5272930 0.88 SPHK2 (0.34) MEN1KMT2A
SCHEMBL5278178 0.86 ALDH1A1 (0.35)
SCHEMBL5276249 0.86 SMYD2 (0.33) CHEK1
SCHEMBL5801918 0.85 P2RY12 (0.34) CHEK1
SCHEMBL4695001 0.83 CD274 (0.46)
SCHEMBL5803928 0.83 MAOB (0.35)
SCHEMBL4695640 0.82 PDCD1 (0.34) ACKR3
SCHEMBL5810881 0.81 SMN1; SMN2 (0.37) CHEK1
SCHEMBL4695511 0.80 PDCD1 (0.34)
SCHEMBL5276039 0.79 PDCD1 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1856048-A1 BIPHENYL COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGONISTS Theravance, Inc. (US) 2007-11-21 EP disclosed
WO-2006098999-A1 BIPHENYL COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGONISTS THERAVANCE, INC. (US) 2006-09-21 WO disclosed